Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Muenster

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 12, 2025
Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 1: in vitro modeling of VericiguatPaul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
Journal of Pharmaceutical Sciences|October 23, 2020
Characteristics of Contents of Lower intestine in the 65-74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release ProductsMaria Vertzoni, Sarah Sulaiman, Konstantinos Goumas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 4, 2025
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguatPaul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 14, 2016
[Preparation of budesonide sustained-release dry powder for inhalation and influence of lactose content]Zheng-lin Liang, Xiu-hua Wang, Rui Ni, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 21, 2016
Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipineCord J Andreas, Irena Tomaszewska, Uwe Muenster, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2017
Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterizationRui Ni, Uwe Muenster, Jing Zhao, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 28, 2020
Engineering large porous microparticles with tailored porosity and sustained drug release behavior for inhalationXiaofei Zhang, Lu Qin, Jian Su, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 15, 2011
Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensionsUwe Muenster, Christian Pelzetter, Thomas Backensfeld, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 30, 2018
Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and doseLan Zhang, Linglong Yang, Xiaofei Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 10, 2016
Predicting biopharmaceutical performance of oral drug candidates - Extending the volume to dissolve applied dose conceptUwe Muenster, Wolfgang Mueck, Dorina van der Mey, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 12, 2025
Development of a novel Physiologically Based Biopharmaceutics modeling (PBBM) framework using the Open Systems Pharmacology Suite, Part 1: in vitro modeling of VericiguatPaul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
Journal of Pharmaceutical Sciences|October 23, 2020
Characteristics of Contents of Lower intestine in the 65-74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release ProductsMaria Vertzoni, Sarah Sulaiman, Konstantinos Goumas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 4, 2025
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguatPaul Vrenken, Maria Vertzoni, Sebastian Frechen, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 14, 2016
[Preparation of budesonide sustained-release dry powder for inhalation and influence of lactose content]Zheng-lin Liang, Xiu-hua Wang, Rui Ni, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 21, 2016
Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipineCord J Andreas, Irena Tomaszewska, Uwe Muenster, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 23, 2017
Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterizationRui Ni, Uwe Muenster, Jing Zhao, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 28, 2020
Engineering large porous microparticles with tailored porosity and sustained drug release behavior for inhalationXiaofei Zhang, Lu Qin, Jian Su, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 15, 2011
Volume to dissolve applied dose (VDAD) and apparent dissolution rate (ADR): tools to predict in vivo bioavailability from orally applied drug suspensionsUwe Muenster, Christian Pelzetter, Thomas Backensfeld, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 30, 2018
Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and doseLan Zhang, Linglong Yang, Xiaofei Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 10, 2016
Predicting biopharmaceutical performance of oral drug candidates - Extending the volume to dissolve applied dose conceptUwe Muenster, Wolfgang Mueck, Dorina van der Mey, et al.
Pageof 3